Core Viewpoint - Acadia Healthcare Company, Inc. is a prominent provider in the inpatient behavioral health care sector, focusing on delivering quality services while aiming for financial growth [1] Financial Performance - In Q4 2025, Acadia reported adjusted earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.03 per share, resulting in an earnings surprise of over 164% [2][6] - Despite the earnings surprise, the company's profit declined by 89% year-over-year, while total revenues reached $821.5 million, reflecting a 6.1% increase compared to the previous year, surpassing the expected $799 million [3][6] - The revenue growth was attributed to a 3.1% increase in patient days and a 2.5% rise in admissions, leading to a 4.4% increase in same-facility revenues [3] Future Projections - Acadia anticipates revenues for 2026 to be between $3.37 billion and $3.45 billion, with adjusted EBITDA projected to range from $575 million to $610 million [4][6] - The company's projections indicate a strategic focus on service expansion and operational efficiency optimization, despite challenges such as a decrease in average length of stay and rising expenses [4] Stock Performance - Currently, ACHC's stock price is $21.48, reflecting a 3.09% increase, with fluctuations between a low of $20.88 and a high of $22.27 during the trading day [5] - Over the past year, the stock has seen a high of $42.85 and a low of $11.43, with a market capitalization of approximately $1.94 billion [5]

Core Viewpoint - Acadia Healthcare is a leading provider in the inpatient behavioral health care sector, recognized for its strong performance and unique market position [1]. Financial Performance - In the fourth quarter, Acadia reported adjusted earnings of $0.07 per share, exceeding the Zacks Consensus Estimate of $0.03, resulting in an earnings surprise of +164.15%. This is a decrease from $0.64 per share in the same quarter last year, but the company has consistently surpassed consensus EPS estimates over the last four quarters [3]. - Total revenues for the quarter reached $821.5 million, surpassing the expected $799 million, marking a 6.1% year-over-year increase driven by higher patient days and admissions, as well as increased revenues per patient day. However, this growth was partially offset by a shorter average length of stay and increased expenses [4]. Future Outlook - Acadia anticipates 2026 revenues to be between $3.37 billion and $3.45 billion, with adjusted EBITDA projected to range from $575 million to $610 million [5][6]. - Following the announcement of its fourth-quarter and full-year 2025 results, Acadia's stock experienced a 23% surge, benefiting from a broader market upswing, with a market capitalization of approximately $2 billion [5]. Analyst Ratings - Raymond James maintained an "Outperform" rating for Acadia Healthcare, indicating confidence in the company's future performance despite a recommendation to "hold" the stock [2][6].

Core Viewpoint - Acadia Healthcare (ACHC) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending September 2025, with the actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The upcoming earnings report is scheduled for November 5, and if the results exceed expectations, the stock may rise; conversely, a miss could lead to a decline [2]. - The consensus estimate for quarterly earnings is $0.72 per share, reflecting a year-over-year decrease of 20.9%, while revenues are projected to be $853.31 million, representing a 4.6% increase from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 1.73% higher, indicating a collective reassessment by analysts [4]. - The Most Accurate Estimate for Acadia Healthcare is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -9.79%, suggesting a bearish outlook from analysts [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the deviation of actual earnings from consensus estimates, with positive readings being more reliable [9][10]. - Acadia Healthcare currently holds a Zacks Rank of 4, which complicates the prediction of an earnings beat [12]. Historical Performance - In the last reported quarter, Acadia Healthcare was expected to post earnings of $0.71 per share but achieved $0.83, resulting in a surprise of +16.90% [13]. - Over the past four quarters, the company has exceeded consensus EPS estimates three times [14]. Conclusion - Acadia Healthcare does not appear to be a strong candidate for an earnings beat, and investors should consider additional factors when making decisions regarding the stock ahead of the earnings release [17].